Dunn J M, Groth P E, DeSimone A
Verex Laboratories, Inc., Englewood, CO 80112.
Drug Intell Clin Pharm. 1988 Feb;22(2):142-5. doi: 10.1177/106002808802200209.
Tocainide is a primary analog of lidocaine with antiarrhythmic properties used to treat ventricular rhythm disorders. A 76-year-old man with benign paroxysmal premature ventricular contractions was treated with tocainide and developed a generalized maculopapular lupoid eruption, bleeding from the lips and gingivae, vertigo, gross tremors of the extremities, fever, and short-term memory loss, which required hospitalization. The patient recovered slowly over three months with no permanent sequelae after discontinuing the drug and receiving rigorous supportive care. His excellent physical status and absence of concomitant illness contributed to an uneventful recovery. Tocainide is a potent cardioactive drug with a long biological half-life and should be used with caution.
妥卡尼是利多卡因的主要类似物,具有抗心律失常特性,用于治疗室性节律紊乱。一名76岁患有良性阵发性室性早搏的男性接受了妥卡尼治疗,出现了全身性斑丘疹样狼疮疹、嘴唇和牙龈出血、眩晕、四肢粗大震颤、发热以及短期记忆丧失,这些症状需要住院治疗。在停药并接受严格的支持治疗后,患者在三个月内缓慢康复,没有留下永久性后遗症。他良好的身体状况和无伴随疾病促成了平稳的康复过程。妥卡尼是一种具有长生物半衰期的强效心脏活性药物,使用时应谨慎。